Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.


Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.

We are pleased to announce the publication of a series of articles comparing US and European patent practice in the life sciences sector.  The articles, which have been written in collaboration with US firm Wolf Greenfield, have been published in The Pharma Letter (subscription required):


The Intersection of Regulatory and Patent Exclusivities for the Life Sciences Industry: A Comparative Overview of American and European Schemes

Double Patenting in the USA and Europe

Salt and Solid Form Issues in US and European Patents

Doctrine of Equivalents in US and European Patent Law